Aarey Drugs & Pharmaceuticals Ltd - Financial Result for the Quarter ended 30th Sep'26 (Standalone, INR Lakh)
Aarey Drugs & Pharmaceuticals Ltd · Financial Result · 15 Nov 2026, 12:10 am
Aarey Drugs & Pharmaceuticals Ltd - Financial Result for the Quarter ended 30th Sep'26 (Standalone, INR Lakh) ■ Revenue: 8,862 (+5.3% YoY | +98.6% QoQ) ■ EBITDA: 214 (-19.0% YoY | +61.6% QoQ) ■ EBITDA Margin (%): 2.4 (-72 bps YoY | -55 bps QoQ) ■ PAT: 137 (+33.8% YoY | +33.8% QoQ) ■ EPS (INR): 0.43 (+19.4% YoY | +19.4% QoQ)
Original exchange filing (PDF)
More announcements from Aarey Drugs & Pharmaceuticals Ltd
- Statement of deviation and variation for the quarter ended September 30, 2026 · 15 Nov 2026
- As per attachment · 15 Nov 2026
- 1. The Board of Directors of the Company has considered and approved the Standalone Unaudited Financial Results for the second quarter & half year ended on 30th September, 2026 along with .... · 15 Nov 2026
- To consider and approve the financial results for the period ended September 30, 2026 · 14 Nov 2026
- Aarey Drugs and Pharmaceuticals limited has informed the Exchange about Board Meeting to be held on 14-Nov-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended September 2026 . · 14 Nov 2026
- Aarey Drugs & Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2026 ,inter alia, to consider and approve This is to intimate .... · 14 Nov 2026
- Revised outcome · 07 Oct 2026
- Scrutinizers Report of 36th Annual General Meeting · 06 Oct 2026
